Marek Murias - Toxicology

Author Information

Marek Murias is a distinguished researcher affiliated with the Department of Toxicology at Poznan University of Medical Sciences in Poznan, Poland. His work primarily focuses on toxicology and pharmacology, contributing significantly to the understanding of anticancer mechanisms and the development of therapeutic agents.

Research Contributions

Marek Murias has made substantial contributions to the field of toxicology, particularly in the study of anticancer compounds and genotoxic impurities in pharmaceuticals. His research delves into the modulation of critical signaling pathways, such as Nrf2 and NF-κB, exploring the therapeutic potential of natural compounds and novel chemical derivatives. His work on liposomal nanoformulations, electron paramagnetic resonance imaging, and the synthesis of bioactive molecules underscores his commitment to advancing cancer treatment and drug safety evaluation.

Aliases

Marek Murias is also known by the aliases M Murias and M. Murias in scholarly publications.

Publication and Citation Metrics

Metric	Value
Number of Papers	126
Citation Count	3252
h-index	30

Publications:

Liposomal Nanoformulation as a Carrier for Curcumin and pEGCG—Study on Stability and Anticancer Potential

DOI: 10.3390/nano12081274

Year: 2022

Attenuation of Pancreatic Cancer In Vitro and In Vivo via Modulation of Nrf2 and NF-κB Signaling Pathways by Natural Compounds

DOI: 10.3390/cells10123556

Year: 2021

Genotoxic impurities in pharmaceutical products – regulatory, toxicological and pharmaceutical considerations

DOI: 10.20883/MEDICAL.E502

Year: 2021

Cytotoxic, analgesic and anti-inflammatory activity of colchicine and its C-10 sulfur containing derivatives

DOI: 10.1038/s41598-021-88260-1

Year: 2021

Anticancer activity and toxicity of new quaternary ammonium geldanamycin derivative salts and their mixtures with potentiators

DOI: 10.1080/14756366.2021.1960829

Year: 2021

Comparison of the Impact of Xanthohumol and Phenethyl Isothiocyanate and Their Combination on Nrf2 and NF-κB Pathways in HepG2 Cells In Vitro and Tumor Burden In Vivo

DOI: 10.3390/nu13093000

Year: 2021

Conjugation of Diclofenac with Novel Oleanolic Acid Derivatives Modulate Nrf2 and NF-κB Activity in Hepatic Cancer Cells and Normal Hepatocytes Leading to Enhancement of Its Therapeutic and Chemopreventive Potential

DOI: 10.3390/ph14070688

Year: 2021

Synthesis of sulfanyl porphyrazines with bulky peripheral substituents – Evaluation of their photochemical properties and biological activity

DOI: 10.1016/j.jphotochem.2020.112964

Year: 2021

Multiharmonic electron paramagnetic resonance imaging as an innovative approach for in vivo studies.

DOI: 10.1016/j.freeradbiomed.2020.03.018

Year: 2020

Dynamic Electron Paramagnetic Resonance Imaging: Modern Technique for Biodistribution and Pharmacokinetic Imaging

DOI: 10.1021/acs.jpcc.0c05703

Year: 2020

Why Is Monitoring Immunoglobulin Levels Important?

What Challenges Do RCTs Face in Toxicology?

Why are Toxicology Databases Important?

What Are the Challenges in Biochemical Toxicology?

What Challenges are Involved in Toxicological Experimental Design?

What are Common Toxins That Impact Immune Function?

What is the Impact of Chemical Stability?

Which Substances Can Cause Ventricular Fibrillation?

How do Neutrophils Respond to Toxic Substances?

What Role Does Vitamin K Play in Toxicology?

Partnered Content Networks

Relevant Topics